Biotech Pharmaceutical Co., Ltd.

This study tests an experimental drug called JY016 in people with advanced solid tumors that have a protein called EGFR on their cells. The goal is to find a safe dose and see if the drug can shrink tumors. About 228 adults with cancers like lung, pancreatic, or colorectal cancer…

This early-stage study tests a new drug called JH021 in 60 people with advanced solid tumors that have stopped responding to standard treatments. JH021 is a special antibody designed to attack two cancer-related targets at once. The main goals are to check the drug's safety, find…

This early-stage study tests whether a new drug, EB070, is safe and how the body processes it. About 36 healthy adults will receive a single injection of either the drug or a placebo. Researchers will monitor side effects and measure drug levels in the blood over several months.